GGrantIndex
← Leaderboards

Siegfried Janz

University Of Iowa

$4,531,636
Attributed
$4,531,636
Total exposure
4
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $590.9K · FY200922
$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$4,531,636 · 4

By mechanism

R01$3,927,359 · 1
R21$364,857 · 1
S10$216,933 · 1
P30$22,487 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Iowa

Same institution · by research overlap

Others in their field

Top investigators on “Prevention

Research focus

PreventionGeneticGenesBiologicalMultiple MyelomaPlasma CellsCellsSoundPlasma Cell NeoplasmMalignant NeoplasmsNeoplastic Plasma CellTumorMalignant - DescriptorValidationHematologic NeoplasmsResearch Project GrantsMouse ModelMolecular GeneticsNew Therapeutic TargetInsightInnovationPlasma Cell DevelopmentNeoplasmsTransgenic Organisms

Grant awards (18)

Biological Validation of Candidate Myeloma Driver Genes$358,435
R01 · FY2022 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$28,941
R01 · FY2022 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$365,750
R01 · FY2021 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$192,646
R01 · FY2021 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$365,750
R01 · FY2020 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$163,114
R01 · FY2020 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$578,339
R01 · FY2018 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$12,598
R01 · FY2018 · CA · contact PI
Biological Validation of Candidate Myeloma Driver Genes$362,188
R01 · FY2017 · CA · contact PI
Validation of FOXM1 as a new therapeutic target in high-risk myeloma$165,844
R21 · FY2017 · CA · contact PI
Validation of FOXM1 as a new therapeutic target in high-risk myeloma$199,013
R21 · FY2016 · CA · contact PI
Defining genetic pathways of plasma-cell neoplasia$294,808
R01 · FY2014 · CA · contact PI
Defining genetic pathways of plasma-cell neoplasia$285,690
R01 · FY2013 · CA · contact PI
Leica LMD 7000 Laser Capture Microdissection Microscope$216,933
S10 · FY2013 · OD · contact PI
Defining genetic pathways of plasma-cell neoplasia$303,925
R01 · FY2012 · CA · contact PI
Defining genetic pathways of plasma-cell neoplasia$303,925
R01 · FY2011 · CA · contact PI
Defining genetic pathways of plasma-cell neoplasia$311,250
R01 · FY2010 · CA · contact PI
Cancer Genetics and Computational Biology$22,487
P30 · FY2009 · CA · contact PI